Quarterly EPS earnings growth: ACADIA Pharmaceuticals Inc (ACAD)
ACADIA Pharmaceuticals generates revenue from the sale of patented medications for Parkinson's disease through insurance funds. The growth rate of quarterly earnings per share allows for an assessment of management's actual efficiency, while -27.10 captures the current state of this parameter. Risks are associated with potential disruptions in component logistics. A high reputation in neuroscience establishes the company as a reliable scientific leader for investors.
%20Quarterly%20EPS%20earnings%20growth&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_ACAD_-_ACADIA-Pharmaceuticals_-_Quarterly-EPS-earnings-growth "ACAD acadia-pharm.com Year-over-year net earnings per share growth for the last 12 months (07/04/2022 - 11/14/2026) | 👁️GURU.Markets👁️")
ACADIA Corp (ACAD) - metric breakdowns and financial figures
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- debt and liquidity data:
Total Debt to Capital ACADIA Pharmaceuticals|ACAD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital ACADIA Pharmaceuticals|ACAD - Company Aggregate Debts|Debt to Book Capitalization Ratio ACADIA Pharmaceuticals Inc|ACAD - Company Long-Term Loans and Borrowings|Company Short-Term Debt ACADIA Pharmaceuticals|Quick Ratio acadia-pharm.com
- earnings and valuation multiples information:
ACAD - Net Profit|Projected Future Earnings ACADIA Pharmaceuticals|ACAD - Price to Earnings Ratio|Forward P/E Multiple ACADIA Pharmaceuticals Inc|ACAD - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio ACADIA Pharmaceuticals Inc|ACAD - Operating profit EBITDA|Net earnings per share for the last 12 months ACADIA Pharmaceuticals|ACAD - Earnings per share for the last four quarters|Quarterly EPS earnings growth acadia-pharm.com|ACAD - Expected net earnings per share growth this year|Earnings growth forecast for next year ACADIA Pharmaceuticals
- sales revenue and business income indicators:
Initial company analysis:ACADIA Pharmaceuticals
ACADIA Pharmaceuticals (ACAD) monetizes its CNS therapy research by bringing targeted drugs to market. These operational successes translate into the quarterly growth rate of net earnings per share. This indicator measures the efficiency of R&D investment capitalization while filtering out fundamentally weak assets. Stable growth confirms the company's leadership potential. By analyzing the quarterly dynamics of earnings per share, an investor can timely identify the risks of deep drawdowns.
Who ACADIA Pharmaceuticals competes with
BIIB: Quarterly EPS earnings growth|NBIX - Year-over-year net earnings per share change for the last twelve months|RGC (Regencell) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Axsome Corp|Year-over-year net earnings per share growth for the last 12 months XENE (Xenon Pharmaceuticals)|VKTX (vikingtherapeutics.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Supernus SUPN|CPRX (Catalyst Pharma) - Year-over-year net earnings per share trend for the last twelve months|Denali Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months HRMY (Harmony Corp)|BHVN: Quarterly EPS earnings growth|amylyx.com (AMLX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Trevi Therapeutics, Inc.|PRAX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Anavex Corp (AVXL)|Year-over-year net earnings per share growth for the last 12 months CeriBell EEG CBLL|Quarterly EPS earnings growth PRTA (Prothena Corporation)|Quarterly EPS earnings growth Alector Inc. ALEC|Annexon - Quarterly EPS earnings growth|Omeros Corporation (OMER) - Year-over-year net earnings per share growth for the last 12 months|NGNE: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months AC Immune Inc (ACIU)|Year-over-year net earnings per share growth for the last 12 months VYGR|Quarterly EPS earnings growth neumoratx.com|Year-over-year net earnings per share growth for the last 12 months SCLX (Scilex)|Year-over-year earnings per share growth rate for the last twelve months TVGN|Quarterly EPS earnings growth ACOG (Alpha Cognition Inc.)|Year-over-year net earnings per share change for the last twelve months cogrx.com (CGTX)|Inhibikase Therapeutics - Quarterly EPS earnings growth|cassavasciences.com (SAVA) - Year-over-year net earnings per share growth for the last 12 months|ASRT: Quarterly EPS earnings growth|Coya Therapeutics (COYA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months VistaGen Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months OVID|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals (ABOS)|Year-over-year net earnings per share change for the last twelve months cervomed.com|Quarterly EPS earnings growth ATHE (Alterity Therapeutics Limited)|Quarterly EPS earnings growth Clene Inc CLNN|PepGen Corp - Quarterly EPS earnings growth|jupiterneurosciences.com (JUNS) - Year-over-year net earnings per share growth for the last 12 months|RLMD: Quarterly EPS earnings growth|annovisbio.com (ANVS) - Quarterly EPS earnings growth|GRCE (Grace Therapeutics Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months AIFF (Firefly Neuroscience, Inc.)|Year-over-year earnings per share growth for the last twelve months Klotho Neurosciences Inc (KLTO)|neurosense-tx.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals)|MetaVia Inc. (MTVA) - Earnings per share growth in annualized terms for the last twelve months|NRXS: Year-over-year net earnings per share growth for the last 12 months|HSDT - Quarterly EPS earnings growth|passagebio.com (PASG) - Year-over-year earnings per share growth for the last twelve months|Neuphoria Therapeutics - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences|Earnings per share growth in annualized terms for the last twelve months athira.com ATHA|Quarterly EPS earnings growth ADXN|Quarterly EPS earnings growth alzamend.com (ALZN)|Quarterly EPS earnings growth CYCN (Cyclerion Therapeutics, Inc.)|PTIX - Year-over-year net earnings per share growth for the last 12 months|Pasithea - Quarterly EPS earnings growth|CRGT - Quarterly EPS earnings growth|ATXI: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months BCLI|CARA (Cara Therapeutics, Inc) - Quarterly EPS earnings growth|Chromocell (CHRO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ELYM|Quarterly EPS earnings growth intracellulartherapies.com (ITCI)|Longboard Pharmaceuticals, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months MRNS|NKGN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months NRBO|SAGE: Quarterly EPS earnings growth|synaptogen.com - Year-over-year earnings per one share growth for the last 12 months|TRVN (Trevena) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Vigil Neuro|Year-over-year earnings per share growth for the last twelve months Anew Medical, Inc. (WENA)|CERE (Cerevel Corp) - Year-over-year earnings per one share growth for the last 12 months
